HITPC - Information Exchange Work Group Meaningful Use Stage 3 Subgroup 1 Quality and Efficiency
This work group, chaired by Dave Goetz and featuring members Cris Ross, Chris Tashjian, and Steve Stack, explores key strategies for improving the quality and efficiency of healthcare through Stage 3 of the Meaningful Use (MU) framework. Discussions focus on topics such as administrative simplification, clinical decision support, and e-prescribing. Key questions include how to incorporate electronic transactions not yet covered in earlier stages, what objectives should be revised or introduced, and how to effectively support EHR vendors and providers to enhance healthcare delivery.
HITPC - Information Exchange Work Group Meaningful Use Stage 3 Subgroup 1 Quality and Efficiency
E N D
Presentation Transcript
HITPC - Information Exchange Work GroupMeaningful Use Stage 3 Subgroup 1Quality and Efficiency Chair: Dave Goetz Members: Cris Ross, Chris Tashjian, Steve Stack
How can these areas be addressed in the context of MU Stage 3? • Administrative simplification • Clinical Decision Support • E-prescribing • Questions: • Can the MU framework effectively be used to address those electronic transactions not currently in Stage 1 or Stage 2 as proposed (admin)? • Which Stage 1 or Stage 2 (proposed) objectives should be expanded? • Are there new objectives that need to be created? • Are there Stage 1 or Stage 2 objectives to be deleted or consolidated?
Proposed short term thoughts • Administrative simplification • Which transaction areas could be considered? • Prior authorizations, eligibility checks, claims processing/editing • Which are already addressed in the market? • How would the MU framework address this area? • What would be effective for EHR vendors and providers? • Clinical Decision Support • Await final MU 2 regulations, recommendations from MU WG • E-prescribing • What areas of eRx remain unaddressed? (controlled substances, mail order pharmacies)
